Cutler Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,460
| Closed | -$57K | – | 1022 |
|
|
2023
Q4 | $57K | Sell |
1,460
-40
| -3% | -$1.56K | 0.01% | 639 |
|
|
2023
Q3 | $41K | Sell |
1,500
-400
| -21% | -$10.9K | ﹤0.01% | 735 |
|
|
2023
Q2 | $64K | Buy |
1,900
+1,200
| +171% | +$40.4K | 0.01% | 565 |
|
|
2023
Q1 | $25K | Sell |
700
-133
| -16% | -$4.75K | ﹤0.01% | 799 |
|
|
2022
Q4 | $37K | Buy |
833
+10
| +1% | +$444 | ﹤0.01% | 907 |
|
|
2022
Q3 | $23K | Buy |
+823
| New | +$23K | ﹤0.01% | 1143 |
|
|
2022
Q2 | – | Sell |
-2,100
| Closed | -$71K | – | 1960 |
|
|
2022
Q1 | $71K | Sell |
2,100
-5,500
| -72% | -$186K | ﹤0.01% | 918 |
|
|
2021
Q4 | $293K | Sell |
7,600
-1,900
| -20% | -$73.3K | 0.01% | 557 |
|
|
2021
Q3 | $512K | Buy |
9,500
+3,200
| +51% | +$172K | 0.02% | 412 |
|
|
2021
Q2 | $210K | Buy |
+6,300
| New | +$210K | 0.01% | 716 |
|
|
2018
Q1 | – | Sell |
-13
| Closed | – | – | 1881 |
|
|
2017
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 2189 |
|
|
2017
Q3 | $0 | Sell |
13
-20
| -61% | – | ﹤0.01% | 2525 |
|
|
2017
Q2 | $1K | Sell |
33
-1,260
| -97% | -$38.2K | ﹤0.01% | 2637 |
|
|
2017
Q1 | $70K | Sell |
1,293
-757
| -37% | -$41K | ﹤0.01% | 1305 |
|
|
2016
Q4 | $108K | Sell |
2,050
-87
| -4% | -$4.58K | ﹤0.01% | 1154 |
|
|
2016
Q3 | $129K | Buy |
2,137
+40
| +2% | +$2.42K | 0.01% | 987 |
|
|
2016
Q2 | $138K | Sell |
2,097
-67
| -3% | -$4.41K | 0.01% | 855 |
|
|
2016
Q1 | $122K | Sell |
2,164
-1,010
| -32% | -$56.9K | 0.01% | 833 |
|
|
2015
Q4 | $746K | Buy |
+3,174
| New | +$746K | 0.04% | 276 |
|